Catalyst Wire Dossier Catalyst Wire Dossier

Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)

9-nitro-20(S)-camptothecin liposomal formulation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC), covering 2010-01-07 to 2010-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) [Phase 2]

See pricing